Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

See Release

All News

Archives

Endologix Receives FDA Approval for Alto Abdominal Stent Graft System

Endologix LLC Comments on Recent FDA Update on Type III Endoleaks with AFX® Endovascular AAA System

Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market

Endologix Receives IDE Approval for the Nellix Chimney EndoVascular Aneurysm Sealing Protocol

Endologix Announces Reinstatement of CE Mark for its Nellix EndoVascular Aneurysm Sealing System